Immunoreactive serum erythropoietin concentrations were measured in 35 patients with anaemia associated with active rheumatoid arthritis.
Abstract
Immunoreactive serum erythropoietin concentrations were measured in 35 patients with anaemia associated with active rheumatoid arthritis.
Based on an evaluation of stainable iron in the bone marrow (marrow iron grade 0-4) and serum ferritin concentrations (concentrations 660 tg/l compatible with iron deficiency) the anaemia was found to be complicated by iron deficiency in 19/35 (54%) of the patients.
The mean serum erythropoietin level (57.6 (SD) 27.3) U/I) was sufficiently raised for the degree of anaemia irrespective of the size of the marrow iron stores. Thus the data do not support the contention that suppressed secretion of erythropoietin is involved in the pathogenesis of anaemia of chronic disorders.
There was a significant inverse correlation between the haemoglobin concentration and log serum erythropoietin in the patients with rheumatoid arthritis.
In the patients with adequate iron stores, but not in the iron depleted patients, there was a tendency for serum erythropoietin concentrations to correlate positively both with C reactive protein and erythrocyte sedimentation rate.
Red cell distribution width (mean (SD) 16-3 (1-8)%) was above normal (11-5-14-5%) both in the iron replete and the iron depleted patients, and the mean red cell distribution width values did not differ significantly among the two subpopulations.
The plasma lactoferrin concentration (mean (SD) 137-6 (109.9) [tg/l) was normal and did not differ significantly between the iron deficient patients and those with adequate iron.
The pathogenesis of the anaemia of chronic disorders, which regularly accompanies active rheumatoid arthritis, is still largely unknown. ' In patients with rheumatoid arthritis stereotypic disturbances of iron metabolism are found, which include hypoferraemia and a universal accumulation of iron in the macrophages. This reticuloendothelial iron blockade may critically deprive the bone marrow of an adequate iron supply.2 On the other hand, marrow erythropoiesis seems to be suppressed by unknown inhibitory mechanisms, which are independent of the compromised iron supply. 3 The 3) . Both the mean ESR (80 5 (30 9) mm/h) and mean serum CRP concentrations (105-8 (90) mg/l) were significantly higher in the iron replete patients than in the iron depleted patients (ESR 64-0 (26 8) mm/h; serum CRP 66-1 (52 1) mg/l). The significance levels were for serum CRP p<0.02 and for ESR 0 02<p<0 05 (unpaired Mann-Whitney U test).
Furthermore, in the patients with adequate iron, but not in the iron depleted patients, there was a tendency for serum erythropoietin concentrations to correlate positively both with ESR and serum CRP (rs=0 59; 01l>p>005; Spearman's rank correlation coefficient). Haemoglobin concentrations in patients with adequate iron also tended to correlate inversely with ESR (r,=-0 79; 00l<p<002, Spearman's rank correlation coefficient).
Both in patients with adequate iron and in the subpopulation with deficient iron the erythrocytes were found to belong to the heterogeneous, normocytic category as assessed by red cell distribution width analysis.
Although the mean red cell distribution width (16-3 (1-8) %) was significantly higher in both groups of patients with rheumatoid arthritis Discussion The compensatory secretory erythropoietin response was found to be adequate for the degree of anaemia in our patients with active rheumatoid arthritis. Moreover, the release of erythropoietin was appropriate irrespective of whether the anaemia was complicated by iron deficiency or not. Even though the slope of the log erythropoietin haemoglobin curve was significantly flatter than the corresponding curve found in patients with non-nephrogenic amaenia, only limited importance is attributed to this finding. The fact that all the anaemic patients with rheumatoid arthritis had moderate anaemia only, whereas the patients with nonnephrogenic anaemia included some cases of grave anaemia with very high erythropoietin concentrations must be taken into account. Because concentrations of erythropoietin rise exponentially with decreasing haemoglobin values these severely anaemic patients exert a strong influence on the course of the log erythropoietin haemoglobin curve. In fact, when the regression line of the anaemic patients with rheumatoid arthritis was compared with the corresponding regression of the patients with multiple myeloma who had a comparable degree of anaemia (haemoglobin >80 g/l), no significant difference was observed. What seems to be more essential is that the serum erythropoietin concentrations found in our patients with rheumatoid arthritis fall within the expected range for the patients with nonnephrogenic anaemia, even though they tend to cluster in the lower part of this range (fig 3) .
In keeping with the findings ofother studies6 7 our data indicate that deficient secretion of erythropoietin is not involved in the pathogenesis of the anaemia associated with active rheumatoid arthritis.
In accord with the observations by Birgegaard et al7 we also found evidence to support the contention that serum erythropoietin concentrations tend to increase in proportion to the degree of inflammatory activity in active rheumatoid arthritis.
In a series of less convincing older investigations, which relied on an insensitive bioassay for the measurement of serum erythropoietin concentrations, it was originally claimed that serum erythropoietin was generally insufficiently low for the degree of anaemia in rheumatoid arthritis.'5 16 Some recent studies, also, based on sensitive radioimmunoassay of serum erythropoietin concentrations seem to confirm the existence of a blunted secretion of erythropoietin in anaemic patients with active rheumatoid arthritis.4 5 The biological significance of marginally or modestly decreased serum erythropoietin concentrations which has been noted by some authors4 5 adequate erythropoiesis still remain to be defined for different degrees of reduction in red cell mass. On the other hand, this does not rule out the possibility that the sensitivity of the erythroid stem cells to the stimulatory effect of erythropoietin might be critically lowered in anaemia of chronic disorders. The possible existence of a decreased bone marrow sensitivity to erythropoietin seems to agree well with the recently obtained clinical experience that dose requirements of recombinant human erythropoietin are radically increased in chronic haemodialysis during infectious episodes or in conjunction with surgery. 7 In addition, in vitro studies have clearly shown that interleukin 1 exerts a dose dependent inhibition on erythropoietin induced formation of erythroid colonies, which can be overcome by excessive doses of recombinant human erythropoietin.
The semiquantitative estimation of stainable iron in the bone marrow remains a valuable standard in the measurement of body iron stores. This study is the first to introduce a systematic evaluation of both stainable marrow iron and serum ferritin in the assessment of serum erythropoietin concentrations. Variations of marrow iron grade in our patients however, were found not to be associated with changes in serum erythropoietin concentrations. This dual estimation of body iron content also allowed a reappraisal of the value of serum ferritin as an indicator of complicating iron deficiency in rheumatoid arthritis. Our results confirm that a serum ferritin concentration -60 .tg/l, which is about five times higher than the corresponding threshold value in normal subjects, will predict iron deficiency in 80% of patients. 19 Bessmann et al presented data to support the contention that the red cell distribution width is valuable in distinguishing between iron deficiency anaemia, which is associated with increased values of red cell distribution width, and anaemia of chronic disorders, in which normal values are found.20 Our data, however, clearly contradict these original findings. In this study red cell distribution width values in patients with depleted iron stores did not significantly differ from values in the patients with rheumatoid arthritis with adequate iron stores. In both subpopulations of anaemic patients with rheumatoid arthritis red cell distribution width was significantly higher than normal. In recent studies on red cell distribution width values in patients with anaemia of chronic disorders an increased heterogeneity of erythrocyte size has also been shown. 2' It has been suggested that lactoferrin is involved in the pathogenesis of anaemia of chronic disorders owing to its ability to translocate iron to intracellular ferritin in cells from the monocyte/macrophage system. 22 
